NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

As for why I imagine he added it on the list in the first place:

The stock apparently has witnessed a growing level of short interest. The last thing that was approved in GBM was TMZ in 2005. Positive interim news for a Phase III continue could cause the stock to rise considerably. It signals that the treatment may not be futile which is what shorts were betting on. And those shorts would then begin to close their position, or perhaps be "short-squeezed" encouraged to close it out. Guess what happens to the IBB when it does this? It goes up a fraction. Why? Because NO SINGLE event implies that not "one" event by itself could do it. And it's isn't laughable that having positive EVENTS (which by the way is a plural word) across different biotechs within a sector to help spark a rebound. It is a cumulative effect that would help lift it to rebound territory.

What's interesting to me is had he instead put NWBO as a potential biotech whose GBM interim event would be a rebound catalyst on his list, I imagine this iHub would be buzzing with approval. In fact, I'm certain of it. But since it is another "GBM" company that made it on HIS list, instead his choice to name a competitor is "laughable". Clearly what is going on is folks are letting their feelings of distain towards a biotech writer affect their judgment.